MKC heads into its September 29 earnings release with options traders at their most defensive in months, even as short sellers quietly rebuild positions after a bruising summer for the stock.
The sharpest signal this week is in the options market. Put demand has jumped well above its recent baseline — the put/call ratio hit 0.64 on Monday and Tuesday, nearly 2.7 standard deviations above its 20-day mean of 0.49. That's not a panic reading, but it is the most hedged options positioning MKC has seen in several months, and the timing — six days before a quarterly print — is hard to ignore. The ratio had been tracking steadily below 0.50 throughout August and into early September before spiking sharply after September 14. Something on the Street changed that week.
The something, most likely, is the analyst community. In the week before September 18, two significant moves landed in quick succession. TD Cowen's Robert Moskow downgraded the stock to Hold from Buy and cut his target from $60 to $55 — the more notable of the two actions. JP Morgan's Thomas Palmer kept his Overweight rating but trimmed his target a dollar to $62. Neither move is catastrophic, but together they reflect a Street increasingly nervous about what the print will show. The consensus mean target now sits around $60, against a stock trading at $49.42. That implied upside looks generous on paper, but targets have been drifting lower for months — Bernstein cut from $77 to $68 after the last quarter, and Barclays trimmed in late June — so the headline gap flatters the picture. Factor scores reinforce the caution: the forward EPS year-on-year percentile sits at just 4, and analyst recommendation momentum ranks in the 5th percentile. Growth expectations, in other words, are not the bull case here.
Short interest complicates the picture in an interesting way. Bears have been rebuilding quickly — SI as a percentage of free float has risen roughly 18% over the past month to 6.6%, a meaningful step-up. The September 9 data shows a visible jump in shares short, from around 13 million to over 16 million, that has largely held since. At the same time, the borrow market remains thoroughly untroubled. Cost to borrow has eased to just 0.41%, down 13% on the week, and availability is running near 482% — meaning lenders hold roughly five shares for every one currently borrowed. The lending pool is loose, and the ORTEX short score of 51 is firmly mid-range, ranking in the 23rd percentile. Shorts are adding, but this is a tactical positioning story rather than a high-conviction squeeze setup.
One ownership wrinkle deserves a mention. MKC has two Schedule 13D filers on its register — both insiders, not outside activists. CEO Brendan Foley filed a 13D in February 2026 disclosing a 5.1% stake, and former CEO Lawrence Kurzius, still a 10% owner, filed a 13D/A in August showing his stake trimmed from 11.8% to 9.9%. The insider data shows Kurzius exercised and sold shares worth roughly $10.8 million in August — a material transaction, though the exercise-and-sell pattern is a common compensation mechanic rather than a pure conviction signal. More telling is a small but clean open-market purchase by Director Michael Conway in July: 1,100 shares at $50.21, done without a 10b5-1 plan. At current prices below that level, that buy is underwater. Stakes are as last disclosed, and a holder who drops below 5% may not file again, so the Kurzius position could have shifted further since the August filing.
The stock itself is down 11% over the past month and off roughly 27% year to date, trading at $49.42. The price-to-earnings multiple has compressed by more than two points in 30 days to around 15.3x. Price-to-book has dropped nearly a quarter-point in a month to 1.77x. Packaged food peers have not been spared either — KHC fell about 3% on the week and BGS dropped 3.8%, suggesting sector-level pressure rather than an MKC-specific problem. The last quarterly print in June produced a sharp positive reaction — the stock rose 7.2% the following day and nearly 12% over the subsequent five sessions — so the market has shown it can rebound hard on good news. Whether the setup is comparable this time is the question September 29 will answer.
What to watch heading into the print: whether the Cowen downgrade proves prescient on consumer demand trends, how the options skew behaves in the final sessions before the release, and whether Kurzius's continued stake reduction resumes after the quiet period lifts.
See the live data behind this article on ORTEX.
Open MKC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
